glucose, (beta-d)-isomer has been researched along with Shock, Septic in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (16.13) | 18.7374 |
| 1990's | 7 (22.58) | 18.2507 |
| 2000's | 10 (32.26) | 29.6817 |
| 2010's | 6 (19.35) | 24.3611 |
| 2020's | 3 (9.68) | 2.80 |
| Authors | Studies |
|---|---|
| Buharalioglu, CK; Cil, M; Guden, DS; Korkmaz, B; Malik, KU; Sahan-Firat, S; Sari, AN; Senol, SP; Temiz-Resitoglu, M; Tunctan, B; Unsal, D | 1 |
| Kandalintseva, N; Lemza, A; Menshchikova, E; Safronova, O; Sharkova, T; Tkachev, V; Vavilin, V; Zenkov, N | 1 |
| Balza, E; Carta, S; Castellani, P; Gattorno, M; Lavieri, R; Piccioli, P; Rubartelli, A; Semino, C | 1 |
| Cañadas, O; Casals, C; Fenutría, R; Figueras, M; Lozano, F; Mota, R; Sarrias, MR; Vera, J; Williams, DL; Yelamos, J | 1 |
| Hristova, M; Ivanovska, N; Yordanov, M | 1 |
| Caputi, AP; Catalano, P; Cuzzocrea, S; Di Paola, R; Genovese, T; Li, JH; Massuda, E; Xu, W; Zhang, J | 1 |
| Chouker, A; Hoelzl, A; Hummel, T; Kaufmann, I; Peter, K; Schliephake, F; Thiel, M | 1 |
| Thiemermann, C | 1 |
| Cox, C; DeAsla, R; DeKing, D; DeLong, DJ; Goldstein, B; Kempski, MH; Lund, N; Stair, D; Tipton, RB; Woolf, PD | 1 |
| Chiara, O; Fattori, L; Padalino, P; Ravizzini, C; Tiberio, G; Turconi, MG | 1 |
| Caputi, AP; Costantino, G; Cuzzocrea, S; Mazzon, E | 1 |
| deBoisblanc, B; Kantrow, SP; Taylor, DE | 1 |
| Ameli, M; Joyce, LD; Lillehei, RC; Mauer, HG; Smith, JM | 1 |
| Buurman, WA; Maessen, JG; van der Linden, CJ; von Asmuth, EJ | 1 |
| Bahrami, S; Goris, RJ; Lieners, C; Redl, H; Schlag, G; van Bebber, IP | 1 |
| Hsueh, W; Sun, XM; Torre-Amione, G | 1 |
| Cook, JA; Halushka, PV; Rogers, TS; Wise, WC | 1 |
| Andersen, OK; Giercksky, KE; Lundgren, TI; Revhaug, A | 1 |
| Reichard, SM | 1 |
| Bullis, HR; Herndon, BL; Ringle, DA | 1 |
| Dyck, JRB; Ferdaoussi, M; Maayah, ZH; Soni, S; Takahara, S | 1 |
| Bao, Y; Huang, Y; Li, N; Song, Z; Sun, L; Sun, Y; Wang, G; Wang, S; Wei, F; Yu, C; Zheng, L; Zhu, H | 1 |
| Chen, H; Guan, Z; Shao, F; Zhang, Y; Zhou, L | 1 |
| Chen, X; Cui, Y; Gao, H; Kang, N; Li, J; Li, X; Liu, X; Liu, Y; Wang, C; Xu, QM; Yang, S; Zhang, Z; Zou, Y | 1 |
| Kufel, WD; Scrimenti, A; Steele, JM | 1 |
| Chen, XG; Fu, FH; Gao, YB; Jiang, WL; Tian, JW; Zhu, HB | 1 |
| Cho, W; Lee, KT; Rim, HK; Sung, SH | 1 |
| Chang, HW; Jung, JS; Kim, SK; Lee, KS; Lee, SW; Li, G; Seo, CS; Son, JK; Song, DK; Xu, ML | 1 |
| Huang, Q; Huang, X; Jin, C; Kan, W; Liu, J; Yan, WS; Zhao, KS | 1 |
| Ling, ZY; Lu, ZY; Shu, SY; Wang, XY | 1 |
| Dhainaut, JF; Lefèvre, G; Raichvarg, D; Tallet, F | 1 |
1 review(s) available for glucose, (beta-d)-isomer and Shock, Septic
| Article | Year |
|---|---|
Classical corticosteroids and new lipid peroxidation inhibitors in the therapy of multiple organ failure (MOF).
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Antioxidants; Clinical Trials as Topic; Free Radical Scavengers; Humans; Injections, Intraperitoneal; Lipid Peroxidation; Methylprednisolone; Multiple Organ Failure; Pregnatrienes; Prospective Studies; Rabbits; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome; Sepsis; Shock, Septic; Zymosan | 1997 |
30 other study(ies) available for glucose, (beta-d)-isomer and Shock, Septic
| Article | Year |
|---|---|
NF-κB activation mediates LPS-or zymosan-induced hypotension and inflammation reversed by BAY61-3606, a selective Syk inhibitor, in rat models of septic and non-septic shock.
Topics: Animals; Cyclooxygenase 2; Disease Models, Animal; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Hypotension; Inflammation; Interleukin-8; Lipopolysaccharides; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Niacinamide; Nitric Oxide Synthase Type II; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Wistar; Shock, Septic; Syk Kinase; Tumor Necrosis Factor-alpha; Zymosan | 2019 |
Water-soluble phenol TS-13 combats acute but not chronic inflammation.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Antioxidant Response Elements; Antioxidants; Arthritis, Experimental; Carrageenan; Chronic Disease; Edema; Foot; Glutathione S-Transferase pi; Granulocytes; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Leukocyte Count; Lipopolysaccharides; Male; Mice, Inbred BALB C; NF-E2-Related Factor 2; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger; Shock, Septic; Solubility; Thiosulfonic Acids; Water; Zymosan | 2014 |
Proton pump inhibitors protect mice from acute systemic inflammation and induce long-term cross-tolerance.
Topics: Animals; Cryopyrin-Associated Periodic Syndromes; Esomeprazole; Gene Expression Regulation; Humans; Interleukin-1beta; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Monocytes; Omeprazole; Peritonitis; Primary Cell Culture; Proton Pump Inhibitors; Shock, Septic; Signal Transduction; Survival Analysis; Thioglycolates; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Zymosan | 2016 |
The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome.
Topics: Animals; Bacteria; Candida albicans; CD5 Antigens; Cell Line; Cell Wall; Cryptococcus neoformans; Cytokines; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Male; MAP Kinase Signaling System; Mice; Schizosaccharomyces; Shock, Septic; Zymosan | 2009 |
Effect of fangchinoline in murine models of multiple organ dysfunction syndrome and septic shock.
Topics: Alkaline Phosphatase; Alkaloids; Animals; Benzylisoquinolines; Complement System Proteins; Escherichia coli Infections; Liver; Macrophages, Peritoneal; Male; Mice; Mice, Inbred ICR; Multiple Organ Failure; Organ Size; Shock, Septic; Spleen; Time Factors; Tumor Necrosis Factor-alpha; Zymosan | 2003 |
Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice.
Topics: Acute Disease; Amides; Animals; Glycoside Hydrolases; Interleukin-1; Male; Malondialdehyde; Mice; Mice, Inbred Strains; Multiple Organ Failure; Peritonitis; Peroxidase; Shock, Septic; Tannins; Tumor Necrosis Factor-alpha; Zymosan | 2004 |
Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity.
Topics: C-Reactive Protein; Calcimycin; Calcitonin; CD18 Antigens; Humans; Hydrogen Peroxide; Interleukin-6; Leukocyte Count; Middle Aged; Multiple Organ Failure; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Opsonin Proteins; Phagocytosis; Protein Precursors; Sepsis; Severity of Illness Index; Shock, Septic; Syndrome; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Zymosan | 2006 |
Beneficial effects of erythropoietin in preclinical models of shock and organ failure.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Endotoxemia; Erythropoietin; Mice; Multiple Organ Failure; Shock; Shock, Hemorrhagic; Shock, Septic; Spinal Cord Injuries; Treatment Outcome; Zymosan | 2007 |
Autonomic modulation of heart rate variability during endotoxin shock in rabbits.
Topics: Animals; Blood Pressure; Catecholamines; Escherichia coli Infections; Heart Rate; Male; Rabbits; Respiration; Shock, Septic; Zymosan | 1995 |
Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat.
Topics: Acetylcysteine; Animals; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Free Radical Scavengers; Leukocyte Count; Male; Multiple Organ Failure; Nitrates; Nitric Oxide; Peritonitis; Random Allocation; Rats; Rats, Sprague-Dawley; Shock, Septic; Survival Analysis; Time Factors; Zymosan | 1999 |
Tempering the temptation to treat with tempol.
Topics: Animals; Antioxidants; Cyclic N-Oxides; Disease Models, Animal; Humans; Multiple Organ Failure; Rats; Shock, Septic; Spin Labels; Zymosan | 2001 |
Zymosan-induced resistance to endotoxin and hemorrhagic shock.
Topics: Animals; Dogs; Female; Hemodynamics; Male; Mononuclear Phagocyte System; Phagocytosis; Shock, Hemorrhagic; Shock, Septic; Time Factors; Zymosan | 1978 |
Tumour necrosis factor alpha (TNF-alpha) and interleukin 6 in a zymosan-induced shock model.
Topics: Animals; Antibodies, Monoclonal; Complement Activation; Disease Models, Animal; Female; In Vitro Techniques; Interleukin-6; Macrophages; Mice; Peritoneal Cavity; Random Allocation; Shock, Septic; Tumor Necrosis Factor-alpha; Zymosan | 1990 |
SOD in rat models of shock and organ failure.
Topics: Animals; Body Weight; Cattle; Disease Models, Animal; Lipid Peroxidation; Liver; Male; Multiple Organ Failure; Peritonitis; Rats; Rats, Inbred Strains; Shock; Shock, Septic; Superoxide Dismutase; Zymosan | 1990 |
Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor.
Topics: Animals; BCG Vaccine; Endotoxins; Gastrointestinal Diseases; Hypotension; Lipopolysaccharides; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred Strains; Shock, Septic; Tumor Necrosis Factor-alpha; Zymosan | 1990 |
Differential alteration of lipoxygenase and cyclooxygenase metabolism by rat peritoneal macrophages induced by endotoxin tolerance.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Calcimycin; Dinoprostone; Drug Tolerance; Endotoxins; Glucans; Lipoxygenase; Macrophages; Phospholipases A; Prostaglandin-Endoperoxide Synthases; Prostaglandins E; Rats; Shock, Septic; SRS-A; Thromboxane B2; Zymosan | 1986 |
Metabolic burst and motility in granulocytes following trauma and endotoxinaemia in the anaesthetized pig.
Topics: Animals; Blood Pressure; Cell Movement; Escherichia coli Infections; Female; Granulocytes; Leukocyte Count; Luminescent Measurements; Male; Shock, Septic; Swine; Wounds and Injuries; Zymosan | 1986 |
RES stimulation and transfer of protection against shock.
Topics: Adaptation, Physiological; Animals; Choline; Depression, Chemical; Diethylstilbestrol; Endotoxins; Glycogen; Immunization; Iron; Mononuclear Phagocyte System; Oxides; Phagocytosis; Rats; Serum Albumin; Shock, Septic; Shock, Traumatic; Spleen; Stimulation, Chemical; Thorium Dioxide; Time Factors; Tissue Extracts; Wounds and Injuries; Zymosan | 1972 |
Effects of RES-stimulating lipids and zymosan on shock.
Topics: Animals; Carbon; Endotoxins; Female; Fishes; Lipids; Liver; Male; Mice; Mononuclear Phagocyte System; Ovary; Phagocytosis; Rats; Salmonella; Shock, Septic; Shock, Traumatic; Testis; Tourniquets; Zymosan | 1966 |
Empagliflozin suppresses inflammation and protects against acute septic renal injury.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Benzhydryl Compounds; Disease Models, Animal; Glucosides; Inflammation; Male; Mice; Mice, Inbred C57BL; Sepsis; Shock, Septic; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Stevioside Activates AMPK to Suppress Inflammation in Macrophages and Protects Mice from LPS-Induced Lethal Shock.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Diterpenes, Kaurane; Enzyme Activation; Gene Expression Regulation, Enzymologic; Glucosides; HMGB1 Protein; Inflammation Mediators; Interleukin-6; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide Synthase Type II; RAW 264.7 Cells; Shock, Septic | 2021 |
Gastrodin alleviates inflammatory injury of cardiomyocytes in septic shock mice via inhibiting NLRP3 expression.
Topics: Animals; Benzyl Alcohols; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Glucosides; Inflammation; Interleukin-1beta; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Shock, Septic | 2021 |
Isoacteoside, a dihydroxyphenylethyl glycoside, exhibits anti-inflammatory effects through blocking toll-like receptor 4 dimerization.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Cells, Cultured; Cyclooxygenase 2; Cytokines; Dimerization; Edema; Female; Glucosides; HEK293 Cells; Humans; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Phenols; RAW 264.7 Cells; Shock, Septic; Toll-Like Receptor 4; Transcription Factor AP-1 | 2017 |
A Case of Septic Shock Due to Serratia marcescens Pyelonephritis and Bacteremia in a Patient Receiving Empagliflozin.
Topics: Aged; Bacteremia; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucosides; Humans; Hypoglycemic Agents; Male; Pyelonephritis; Serratia Infections; Serratia marcescens; Shock, Septic | 2017 |
Paeoniflorin inhibits systemic inflammation and improves survival in experimental sepsis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Blood Urea Nitrogen; Bridged-Ring Compounds; Cecum; Cell Line; Clinical Enzyme Tests; DNA-Binding Proteins; Endotoxins; Glucosides; Hemodynamics; Imipenem; Inflammation; Inflammation Mediators; Intestine, Small; Lactic Acid; Liver; Lung; Macrophages; Male; Membrane Glycoproteins; Mice; Monoterpenes; Peroxidase; Rats; Rats, Sprague-Dawley; Receptors, Immunologic; Shock, Septic; Triggering Receptor Expressed on Myeloid Cells-1 | 2009 |
Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Coumarins; Cyclooxygenase 2; Dinoprostone; Down-Regulation; Drug Interactions; Glucosides; I-kappa B Kinase; I-kappa B Proteins; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Macrophages; Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Promoter Regions, Genetic; Shock, Septic; Signal Transduction; TNF Receptor-Associated Factor 6; Transcription, Genetic; Tumor Necrosis Factor-alpha; Ubiquitination | 2012 |
Preventive agents against sepsis and new phenylpropanoid glucosides from the fruits of Illicium verum.
Topics: Alanine Transaminase; Animals; Fruit; Galactosamine; Glucosides; Illicium; Male; Mice; Mice, Inbred ICR; Phytotherapy; Plant Extracts; Protective Agents; Shock, Septic; Tumor Necrosis Factor-alpha | 2003 |
The mechanism of Polydatin in shock treatment.
Topics: Animals; Calcium Channel Blockers; Calcium Signaling; Cell Adhesion; Cells, Cultured; Drug Evaluation, Preclinical; Endothelial Cells; Endothelium, Vascular; Fallopia japonica; Glucosides; Humans; Intercellular Adhesion Molecule-1; Leukocytes; Microcirculation; Muscle, Smooth, Vascular; Myocardium; Patch-Clamp Techniques; Phytotherapy; Plants, Medicinal; Potassium Channels; Rats; Shock, Hemorrhagic; Shock, Septic; Stilbenes; Verapamil | 2003 |
Effect of polydatin on phospholipase A2 in lung tissues in rats with endotoxic shock.
Topics: Analysis of Variance; Animals; Glucosides; Lung; Male; Phospholipases A; Phospholipases A2; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Shock, Septic; Stilbenes | 2004 |
[Metabolism and septic shock].
Topics: Bacterial Infections; Glucosides; Glycolysis; Humans; Lipid Metabolism; Muscle Proteins; Oxygen; Shock, Septic | 1990 |